FDA Inspection
Bioreliance CorporationBioreliance Corporation – FDA Inspection, Aug 29, 2013
Record Details
This FDA Inspection record concerns Bioreliance Corporation, with an inspection on August 29, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Bioreliance Corporation
- Inspection Date
- August 29, 2013
- Product Type
- Biologics
View Company Profile
ID · 58414ffc-fee2-43b1-9d00-adfdcf78fe1b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 850690
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Bioreliance Corporation
11| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2026 | VAI | Baltimore District Office | Bioresearch Monitoring: Human Drugs |
| November 22, 2024 | VAI | Baltimore District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| August 4, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2019 | Not classified | Baltimore District Office | |
| July 13, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Bioreliance Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.